GENEVA, July 29 -- HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (Jerusalem BioPark, Hadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem) filed a patent application (PCT/IL2025/050037) for "ANTIBODIES DIRECTED TO SLAMF6" on Jan 13, 2025. With publication no. WO/2025/154050, the details related to the patent application was published on Jul 24, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LOTEM, Michal (c/o Hadasit Medical Services and Research Development Ltd.Jerusalem BioPark, Hadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem), EISENBERG, Galit (c/o Hadasit...